The STAR Tumor Ablation Registry

Overview

About this study

The purpose of this registry is to collect clinical safety and outcomes data on the use of the STAR™ Tumor Ablation System on patients with painful cancer matastases of their thoracic or lumbar spine.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Subjects with painful spinal metastatic lesions in thoracolumbar vertebrae that will be treated with t-RFA using the STAR™ Tumor Ablation System

Exclusion Criteria

  • Subjects under 18 years old
  • Subjects with heart pacemakers, or other electronic device implants
  • Subjects intended for t-RFA in vertebral body levels C1-7

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Jonathan Morris, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20178179

Mayo Clinic Footer